A real-world trial of ILUVIEN® (fluocinolone acetonide) in patients with chronic diabetic macular edema (DME)
Phase of Trial: Phase IV
Latest Information Update: 13 Sep 2018
Price : $35 *
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms RETRO-IDEAL
- 13 Sep 2018 According to an Alimera Sciences media release, data from this study will be presented at the 2018 Annual Meeting of the Retina Society (Sep 2018).
- 08 Sep 2017 New trial record
- 05 Sep 2017 According to an Alimera Sciences media release, results from this trial will be presented during the 17th European Society of Retina Specialists Congress (EURETINA) 2017.